< img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=4285980&fmt=gif" />
en
Search
Home
Small Molecule
Mol2Med™ Integrated Services
Developability Assessment
API Form and Solid-State Research
Crystallization Development
Pre-formulation Studies
Formulation and Analytical Development
GMP Manufacturing
Clinical Supply
Biologics
Experienced Leadership and Scientific Team
Outstanding Analytical Techniques
Well-Equipped Laboratory
Broad Ranges of Biologics
Technology
Solid Form Screening
Solid Form Developability Evaluation
Absolute Structure Determination
Crystallization Process Development
Conventional Oral Solid Dosage Forms
Formulation Development for Poorly Water-Soluble Drugs
Mini-Tablet
About Us
Our Company
Our History
Our People
Our Partner
Resources
Company News
Events
Technical Articles
Classic Publications
Webinar Series
Knowledge Hub
Presentations & Webinars
Careers
Talent Recruitment
Contact Us
Home
Small Molecule
Mol2Med™ Integrated Services
Developability Assessment
Solid-State Characterization/FAST
pKa/LogP/LogD Measurements
Stability and Solubility Studies
In-Silico PBPK Modeling and Simulation
API Form and Solid-State Research
Solid Form Screening and Selection
Single Crystal Growth & Structure Determination
Solid-State NMR Analysis
Crystallization Development
Crystallization Development
Chiral Separation
Pre-formulation Studies
Comprehensive Physicochemical Property Evaluation
Excipient Selection and Compatibility Studies
Formulations for PK/Efficacy/Tox Studies
Animal Dosing Vehicle Selection
Amorphous Solid Dispersions
Formulation and Analytical Development
Formulation Development
Oral Solid Dosage Forms
Bioavailability Enhancement Formulations
Pediatric Formulation (Mini-tablet)
Analytical Chemistry
GMP Manufacturing
Clinical and Commercial Manufacturing
Clinical Supply
Biologics
Experienced Leadership and Scientific Team
Outstanding Analytical Techniques
Well-Equipped Laboratory
Broad Ranges of Biologics
Technology
Solid Form Screening
Solid Form Developability Evaluation
Absolute Structure Determination
Crystallization Process Development
Conventional Oral Solid Dosage Forms
Formulation Development for Poorly Water-Soluble Drugs
Mini-Tablet
About Us
Our Company
Our History
Our People
Our Partner
Resources
Company News
Crystal Formulation Services successfully passed the dual certification of GMP and GDP conducted by SGS
Industry Shift: FDA Goes Vegan?
Crystal Pharmatech's CDMO Business Unit - Crystal Formulation Services Received China Drug Product Manufacturing License, Achieving the Important Milestone in Formulation Capability
Crystal Pharmatech Recognized as "Best Partner" by Allorion Therapeutics for Excellent Services
Crystal Pharmatech Returned to AAPS 2022 PharmSci 360
Crystal Pharmatech and Particle Sciences Form a US-China Pharmaceutical CRO Partnership
Crystal Pharmatech Raises $10 Million to Accelerate Growth
Crystal Formulation Services, Formulation Tailor-made for Your Molecules
Candoo Enables the Successful Development of a BCS 4 Combo Drug Product
International Company Crystal Pharmatech Finds CCIT An Optimal Spot for First US Location
Crystal Pharmatech Triples Headquarters in Biobay, China, with More Floors and Labs
Xceleron and Crystal Pharmatech Announce Partnership to Improve Early Clinical Development Utilizing Absolute Bioavailability Trials and Solid-State Solutions
Crystal Pharmatech Introduces Customized Service Packages for Customers Seeking Materials Science Approaches in Drug Discovery and Development
Crystal Pharmatech Expands Leadership Team
Crystal Formulation Services(CFS)Opens New Formulation Development Center and Analytical R&D Lab in Suzhou, China
Candoo's Formulation Technology Platform Featured in the Drug Development & Delivery Journal
Crystal Formulation Services' GMP Manufacturing Facility Successfully Passes the Remote Audit by US Client, Marking a Key Milestone for Its International Expansion
Events
Crystal Pharmatech and the Future of Pharma at AAPS PharmSci 360
CPhI north america - Meet Us at Booth #530
Crystal Pharmatech Raring to Go to ChemOutsourcing 2022
Technical Articles
Case Studies
Whitepaper
ASD Series
Classic Publications
Crystallization of Organic Compounds
Handbook of Industrial Crystallization (3rd Edition)
Polymorphism in Molecular Crystals
Polymorphism in Pharmaceutical Solids
Pharmaceutical Amorphous Solid Dispersions
Pharmaceutical Preformulation and Formulation
Webinar Series
2023-Mol2Med™ First-Time-Right Approach Webinar Series
Selecting the Right API Form and Formulation
Molecules-to-Medicine: Accelerating Drug Development through Collaboration
Advanced Characterization: Tools for Accelerating Molecules to Medicine
Knowledge Hub
Unlock Solubility Enhancement Methods for Poorly Soluble Oral Drugs
Learn about Drug Eutectic Screening
Crystallization Process Method
Fun Sharing: The Secret Behind the Silky Smoothness of Chocolate (Part 2)
Fun Sharing: The Secret behind the Silky Smooth Enjoyment of Chocolate (Part 3)
Fun Sharing: The Secret Behind the Silkiness of Chocolate (Part 1)
Fun Sharing:The Story Between Ice Crystals and Frozen Foods (Part 3)
Fun Sharing: The Relationship Between Ice Crystals and Frozen Foods (Part 1)
Fun Sharing: The Story of Ice Crystals and Frozen Foods (Part 2)
Case Study on Development and Production Applications of Amorphous Solid Dispersions - Hot Melt Extrusion
Development and Production Application Case Study of Amorphous Solid Dispersions: Spray Drying
Amorphous Solid Dispersion Technology and the Service Advantages of Crystal Pharmaceutical
ASD Column | Mastering Stable Art: Unveiling Key Factors Influencing Physical Stability of Amorphous Solid Dispersions
ASD Column | How to Select Polymers in Hot-melt Extrusion Process?
ASD Column | Understanding the ASD Preparation Methods and Selecting the Optimal Method for Solution
Polymorphs, Solvatomorphs and Hydrate of Dabrafenib
Shining Glory: Unveiling the "True Eye" behind the Veil of Drug Crystal Forms
Applications of Dynamic Moisture Adsorption in Crystal Research
Application of Granularity Analysis in Crystal Typing Research
A Brief Introduction to Amorphous Solid Dispersion Technology
Presentations & Webinars
Solid Form Research
Preclinical and Tox Formulation Development
Careers
Talent Recruitment
Contact Us
E-mail us
+1-609-604-8303
bd_global@crystalpharmatech.com
cn
Small Molecule
Mol2Med™ Integrated Services
Developability Assessment
API Form and Solid-State Research
Crystallization Development
Pre-formulation Studies
Formulation and Analytical Development
GMP Manufacturing
Clinical Supply
Solid-State Characterization/FAST
pKa/LogP/LogD Measurements
Stability and Solubility Studies
In-Silico PBPK Modeling and Simulation
Solid Form Screening and Selection
Single Crystal Growth & Structure Determination
Solid-State NMR Analysis
Crystallization Development
Chiral Separation
Comprehensive Physicochemical Property Evaluation
Excipient Selection and Compatibility Studies
Formulations for PK/Efficacy/Tox Studies
Animal Dosing Vehicle Selection
Amorphous Solid Dispersions
Formulation Development
Oral Solid Dosage Forms
Bioavailability Enhancement Formulations
Pediatric Formulation (Mini-tablet)
Analytical Chemistry
Clinical and Commercial Manufacturing
Biologics
Technology
Solid Form Screening
Solid Form Developability Evaluation
Absolute Structure Determination
Crystallization Process Development
Conventional Oral Solid Dosage Forms
Formulation Development for Poorly Water-Soluble Drugs
Mini-Tablet
About Us
Our Company
Our History
Our People
Our Partner
Resources
Company News
Events
Technical Articles
Classic Publications
Webinar Series
Knowledge Hub
Presentations & Webinars
Crystal Formulation Services successfully passed the dual certification of GMP and GDP conducted by SGS
Industry Shift: FDA Goes Vegan?
Crystal Pharmatech's CDMO Business Unit - Crystal Formulation Services Received China Drug Product Manufacturing License, Achieving the Important Milestone in Formulation Capability
Crystal Pharmatech Recognized as "Best Partner" by Allorion Therapeutics for Excellent Services
Crystal Pharmatech Returned to AAPS 2022 PharmSci 360
Crystal Pharmatech and Particle Sciences Form a US-China Pharmaceutical CRO Partnership
Crystal Pharmatech Raises $10 Million to Accelerate Growth
Crystal Formulation Services, Formulation Tailor-made for Your Molecules
Candoo Enables the Successful Development of a BCS 4 Combo Drug Product
International Company Crystal Pharmatech Finds CCIT An Optimal Spot for First US Location
Crystal Pharmatech Triples Headquarters in Biobay, China, with More Floors and Labs
Xceleron and Crystal Pharmatech Announce Partnership to Improve Early Clinical Development Utilizing Absolute Bioavailability Trials and Solid-State Solutions
Crystal Pharmatech Introduces Customized Service Packages for Customers Seeking Materials Science Approaches in Drug Discovery and Development
Crystal Pharmatech Expands Leadership Team
Crystal Formulation Services(CFS)Opens New Formulation Development Center and Analytical R&D Lab in Suzhou, China
Candoo's Formulation Technology Platform Featured in the Drug Development & Delivery Journal
Crystal Formulation Services' GMP Manufacturing Facility Successfully Passes the Remote Audit by US Client, Marking a Key Milestone for Its International Expansion
Crystal Pharmatech and the Future of Pharma at AAPS PharmSci 360
CPhI north america - Meet Us at Booth #530
Crystal Pharmatech Raring to Go to ChemOutsourcing 2022
Case Studies
Whitepaper
ASD Series
Crystallization of Organic Compounds
Handbook of Industrial Crystallization (3rd Edition)
Polymorphism in Molecular Crystals
Polymorphism in Pharmaceutical Solids
Pharmaceutical Amorphous Solid Dispersions
Pharmaceutical Preformulation and Formulation
2023-Mol2Med™ First-Time-Right Approach Webinar Series
Selecting the Right API Form and Formulation
Molecules-to-Medicine: Accelerating Drug Development through Collaboration
Advanced Characterization: Tools for Accelerating Molecules to Medicine
Unlock Solubility Enhancement Methods for Poorly Soluble Oral Drugs
Learn about Drug Eutectic Screening
Crystallization Process Method
Fun Sharing: The Secret Behind the Silky Smoothness of Chocolate (Part 2)
Fun Sharing: The Secret behind the Silky Smooth Enjoyment of Chocolate (Part 3)
Fun Sharing: The Secret Behind the Silkiness of Chocolate (Part 1)
Fun Sharing:The Story Between Ice Crystals and Frozen Foods (Part 3)
Fun Sharing: The Relationship Between Ice Crystals and Frozen Foods (Part 1)
Fun Sharing: The Story of Ice Crystals and Frozen Foods (Part 2)
Case Study on Development and Production Applications of Amorphous Solid Dispersions - Hot Melt Extrusion
Development and Production Application Case Study of Amorphous Solid Dispersions: Spray Drying
Amorphous Solid Dispersion Technology and the Service Advantages of Crystal Pharmaceutical
ASD Column | Mastering Stable Art: Unveiling Key Factors Influencing Physical Stability of Amorphous Solid Dispersions
ASD Column | How to Select Polymers in Hot-melt Extrusion Process?
ASD Column | Understanding the ASD Preparation Methods and Selecting the Optimal Method for Solution
Polymorphs, Solvatomorphs and Hydrate of Dabrafenib
Shining Glory: Unveiling the "True Eye" behind the Veil of Drug Crystal Forms
Applications of Dynamic Moisture Adsorption in Crystal Research
Application of Granularity Analysis in Crystal Typing Research
A Brief Introduction to Amorphous Solid Dispersion Technology
Solid Form Research
Preclinical and Tox Formulation Development
Careers
Contact Us
Preclinical and Tox Formulation Development
Home
Resources
Presentations & Webinars
Preclinical and Tox Formulation Development
Preclinical and Tox Formulation Development
The Use of Amorphous Solid Dispersions to Enhance Dissolution, and Oral Bioavailability of Poorly Water-Soluble Pharmaceutical C
Polymorphism of Drugs - Can We Exploit Physical Form in the Development of Low Solubility Molecules?
Efficient Preclinical Formulation Development for Poorly Soluble Compounds
Pre-clinical Formulation Strategies Sponsored by Crystal Pharmatech
Integrated Phase and Formulation Selection to Support GLP Toxicology and First in Human Studies Sponsored by Crystal Pharmatech
SMART Development of Pre-clinical Candidates
Small Molecule
Mol2Med™ Integrated Services
Developability Assessment
API Form and Solid-State Research
Crystallization Development
Pre-formulation Studies
Formulation and Analytical Development
GMP Manufacturing
Clinical Supply
Technology
Quick Links
About Us
Events
Contact Us
bd_global@crystalpharmatech.com
+1-609-604-8303
U.S
Suite 500-B, 3000 Eastpark Blvd, Cranbury, New Jersey 08512, USA
Canada
6800 Kitimat Rd, Unit 1, Mississauga, Ontario, Canada L5N 5M1
China
Suite B4-101, Biobay, 218 Xinghu Street, Suzhou Industrial Park, Suzhou, China, 215123
Sitemap
Privacy Policy
API Form and Solid-State Research
Solid Form Screening and Selection
Single Crystal Growth & Structure Determination
Solid-State NMR Analysis
Analytical Chemistry
Pre-formulation Studies
Formulation Development
Clinical and Commercial Manufacturing
Technology
Solid Form Screening
Solid Form Developability Evaluation
Absolute Structure Determination
Crystallization Process Development
Conventional Oral Solid Dosage Forms
Formulation Development for Poorly Water-Soluble Drugs
Mini-Tablet
Quick Links
About Us
Knowledge Hub
Events
Suite 500-B, 3000 Eastpark Blvd, Cranbury, New Jersey 08512, USA
bd_global@crystalpharmatech.com
+1-609-604-8303
+1-609-604-8303
Your browser does not support VBScript!